2898. Achieving Hepatitis C SVR12 of 95% in Mono-Infected Patients with Severe Comorbidities Using Volunteer Staff and Minimal Clinic Visits and Phlebotomy

BACKGROUND: HCV is the most common chronic bloodborne infection in the United States with an estimated 3.5 million infected. With direct-acting antivirals, cure can be achieved in 8 to 12 weeks. To achieve WHO elimination targets by 2030 (>90% reduction in incidence) requires increased detection,...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Horst, Charles M, Greenberg, Gary, Kirchgessner, Erin, Vaughn, Amanda, Alfano-Sobsey, Edie, Riggleman, Amy, Soufan, Ayat, Horner, Mandy, Nadabar, Asha, Castillo, Diana, Campbell, Elizabeth, Lynn Ledford, Sue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808893/
http://dx.doi.org/10.1093/ofid/ofz359.176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808893/
http://dx.doi.org/10.1093/ofid/ofz359.176

Ejemplares similares